Medytox Solutions Inc (MMMS) Financial Statements (2025 and earlier)
Company Profile
Business Address |
400 S. AUSTRALIAN AVENUE, SUITE 800 WEST PALM BEACH, FL 33401 |
State of Incorp. | |
Fiscal Year End | December 31 |
Industry (SIC) | 8734 - Testing Laboratories (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
6/30/2015 MRQ | 12/31/2014 | 12/31/2013 | 12/31/2012 | |||
---|---|---|---|---|---|---|
ASSETS | ||||||
Current Assets | ||||||
Cash, cash equivalents, and short-term investments | 2,406 | 4,141 | 1,774 | |||
Cash and cash equivalent | 2,406 | 4,141 | 1,774 | |||
Deposits current assets | 260 | |||||
Prepaid expense and other current assets | ✕ | ✕ | ✕ | 110 | ||
Other undisclosed current assets | 17,663 | 14,297 | 6,695 | |||
Total current assets: | 20,329 | 18,438 | 8,578 | |||
Noncurrent Assets | ||||||
Property, plant and equipment | 7,678 | 2,156 | ||||
Intangible assets, net (including goodwill) | 7,576 | 4,617 | 1,051 | |||
Goodwill | 3,140 | 1,426 | 1,051 | |||
Intangible assets, net (excluding goodwill) | 4,436 | 3,191 | ||||
Deferred tax assets, net | 253 | (42) | ||||
Other undisclosed noncurrent assets | (75) | 139 | 1,219 | |||
Total noncurrent assets: | 15,432 | 6,870 | 2,270 | |||
TOTAL ASSETS: | 35,761 | 25,308 | 10,848 | |||
LIABILITIES AND EQUITY | ||||||
Liabilities | ||||||
Current Liabilities | ||||||
Accounts payable and accrued liabilities | 13,742 | 10,665 | ||||
Taxes payable | 8,088 | 6,053 | ||||
Accounts payable | 3,357 | 1,756 | ||||
Accrued liabilities | 2,297 | 2,856 | ||||
Debt | 3,583 | 3,883 | ||||
Derivative instruments and hedges, liabilities | 380 | |||||
Other undisclosed current liabilities | 443 | 1,502 | 8,978 | |||
Total current liabilities: | 18,148 | 16,049 | 8,978 | |||
Noncurrent Liabilities | ||||||
Long-term debt and lease obligation | 2,316 | 448 | ||||
Long-term debt, excluding current maturities | 93 | 42 | ||||
Capital lease obligations | 2,223 | 406 | ||||
Liabilities, other than long-term debt | 253 | 42 | ||||
Deferred tax liabilities, net | 253 | 42 | ||||
Other undisclosed noncurrent liabilities | 36 | |||||
Total noncurrent liabilities: | 2,569 | 490 | 36 | |||
Total liabilities: | 20,717 | 16,539 | 9,014 | |||
Equity | ||||||
Equity, attributable to parent, including: | 14,923 | 8,648 | 1,710 | |||
Common stock | 3 | 3 | ||||
Additional paid in capital | 5,357 | 1,905 | 617 | |||
Retained earnings | 9,563 | 6,752 | 1,094 | |||
Other undisclosed equity, attributable to parent | 0 | (12) | ||||
Equity, attributable to noncontrolling interest | 121 | 121 | ||||
Total equity: | 15,044 | 8,769 | 1,710 | |||
TOTAL LIABILITIES AND EQUITY: | 35,761 | 25,308 | 10,724 |
Income Statement (P&L) ($ in thousands)
6/30/2015 TTM | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
---|---|---|---|---|---|
Revenues | 77,224 | 52,524 | 21,076 | ||
Revenue, net | 57,928 | ||||
Cost of revenue (Cost of Product and Service Sold) | (15,920) | (9,571) | |||
Gross profit: | 61,303 | 42,953 | 21,076 | ||
Operating expenses | (42,273) | (38,024) | (23,983) | ||
Other undisclosed operating income (loss) | (3,376) | 9,571 | |||
Operating income (loss): | 15,655 | 14,500 | (2,907) | ||
Nonoperating expense | (142) | (619) | |||
Investment income, nonoperating | 134 | ||||
Other nonoperating expense | (273) | (671) | |||
Interest and debt expense | (526) | (475) | 654 | ||
Income (loss) from continuing operations before income taxes: | 14,986 | 13,406 | (2,253) | ||
Income tax expense | (7,561) | (5,569) | |||
Income (loss) from continuing operations: | 7,425 | 7,838 | (2,253) | ||
Income (loss) before gain (loss) on sale of properties: | 7,425 | 7,838 | (2,253) | ||
Other undisclosed net income | 395 | 422 | |||
Net income (loss): | 7,820 | 8,260 | (2,253) | ||
Other undisclosed net income (loss) attributable to parent | (5,010) | (2,601) | 5,000 | ||
Net income attributable to parent: | 2,810 | 5,659 | 2,747 | ||
Preferred stock dividends and other adjustments | (5,010) | (2,601) | |||
Net income (loss) available to common stockholders, basic: | (2,200) | 3,057 | 2,747 | ||
Dilutive securities, effect on basic earnings per share | 14 | ||||
Other undisclosed net income available to common stockholders, diluted | 5,010 | ||||
Net income available to common stockholders, diluted: | 2,824 | 3,057 | 2,747 |
Comprehensive Income ($ in thousands)
6/30/2015 TTM | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
---|---|---|---|---|---|
Net income (loss): | 7,820 | 8,260 | (2,253) | ||
Comprehensive income (loss), net of tax, attributable to parent: | 7,820 | 8,260 | (2,253) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.